Following the decriminalization of psilocybin-containing mushrooms (“magic mushrooms”) by Denver voters in Could, Sträva has begun exploring the rewards and dangers of combining micro-doses of psilocybin with their specialty coffees, which includes CBD-infused coffees.
“Just as cannabis has been misunderstood and controversial for decades, psilocybin from mushrooms has been equally polarizing, however proponents of each recommend they every can contribute meaningfully to the human practical experience,” stated Sträva CEO Andrew Aamot. “As study is proving, with measured consumption, cannabis and psilocybin can each market physiological, mental and spiritual well being.”
Psilocybin is naturally occurring in more than 180 species of mushrooms. It stimulates serotonin receptors in the brain and is believed to expand neural activity. Standard medicine and cultural rituals have embraced mushrooms for centuries for this explanation contemporary science is now providing validation. A 2013 study performed by the University of South Florida showed that psilocybin acted to stimulate development of new brain cells, though a 2014 study published in The Journal of Royal Society Interface demonstrated enhanced neural connectivity in the brain.
Designated by the FDA as a “breakthrough therapy,” the study of psilocybin for remedy of anxiousness, addiction and resistant depression, is gaining traction. 2006 and 2011 research by the University of Arizona showed “promising trends toward decreased psychological distress” applying low-moderate (14mg/70kg) and (10mg, 25mg/70kg) doses.
By incorporating micro-doses of psilocybin into coffee and tea, Sträva aims to empower customers with access to organic compounds which may well supply life-altering rewards.